PRVAPrivia Health Group, Inc.

Nasdaq priviahealth.com


$ 19.09 $ 0.27 (1.44 %)    

Wednesday, 18-Sep-2024 15:59:59 EDT
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 19.07
$ 18.74
$ 19.06 x 200
-- x --
$ 18.74 - $ 20.00
$ 15.92 - $ 24.35
1,001,157
na
2.28B
$ 0.73
$ 152.70
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 11-03-2023 09-30-2023 10-Q
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-25-2022 12-31-2021 10-K
12 11-08-2021 09-30-2021 10-Q
13 08-09-2021 06-30-2021 10-Q
14 05-28-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 baird-maintains-outperform-on-privia-health-gr-raises-price-target-to-24

Baird analyst Michael Ha maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and raises the price target from $23 to ...

 rbc-capital-reiterates-outperform-on-privia-health-gr-maintains-28-price-target

RBC Capital analyst Sean Dodge reiterates Privia Health Gr (NASDAQ:PRVA) with a Outperform and maintains $28 price target.

 privia-health-gr-q2-2024-adj-eps-019-beats-005-estimate-sales-422326m-miss-706445m-estimate

Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $0.0...

 evercore-isi-group-maintains-outperform-on-privia-health-gr-lowers-price-target-to-20

Evercore ISI Group analyst Elizabeth Anderson maintains Privia Health Gr (NASDAQ:PRVA) with a Outperform and lowers the pric...

 baird-initiates-coverage-on-privia-health-gr-with-outperform-rating-announces-price-target-of-23

Baird analyst Michael Ha initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Outperform rating and announces Price T...

 barclays-maintains-equal-weight-on-privia-health-gr-lowers-price-target-to-19

Barclays analyst Andrew Mok maintains Privia Health Gr (NASDAQ:PRVA) with a Equal-Weight and lowers the price target from $2...

 truist-securities-maintains-buy-on-privia-health-gr-lowers-price-target-to-24

Truist Securities analyst Jailendra Singh maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target fr...

 canaccord-genuity-maintains-buy-on-privia-health-gr-lowers-price-target-to-26

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from...

 privia-health-gr-q1-2024-adj-eps-018-beats-005-estimate-sales-415243m-miss-679999m-estimate

Privia Health Gr (NASDAQ:PRVA) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.0...

 stifel-maintains-buy-on-privia-health-gr-lowers-price-target-to-24

Stifel analyst Craig Jones maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $28 to $24.

 citigroup-initiates-coverage-on-privia-health-gr-with-buy-rating-announces-price-target-of-25

Citigroup analyst Daniel Grosslight initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Buy rating and announces Pri...

 canaccord-genuity-maintains-buy-on-privia-health-gr-lowers-price-target-to-37

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION